Logo do repositório
 
Publicação

The Prevalence of COVID-19 Fog and the Impact on Quality of Life After SARS-CoV-2 Infection (QoL-COVID)

2023-10Artigo científico Acesso aberto
Ver registo simples
dc.contributor.authorDe Figueiredo, Inês Rego
dc.contributor.authorFerrão, Joana Branco
dc.contributor.authorDias, Sara
dc.contributor.authorBorges, Diogo Drummond
dc.contributor.authorFernandes, Jorge
dc.contributor.authorBernardino, Vera
dc.contributor.authorGruner, Heidi
dc.contributor.authorPanarra, António
dc.contributor.institutionNOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
dc.contributor.pblBiblioteca Nacional de Portugal, Centro de Estudos Históricos, CELOM
dc.date.accessioned2025-03-18T21:38:13Z
dc.date.available2025-03-18T21:38:13Z
dc.date.issued2023-10
dc.descriptionFunding Information: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Publisher Copyright: © Ordem dos Médicos 2023.
dc.description.abstractIntroduction: Coronavirus has an impact on both the physical and mental health of individuals. The literature regarding the patient’s health status post- SARS-CoV-2 is still scarce with limited data on the prevalence of residual symptoms and quality of life (QoL) after the infection. The aim of this study was to understand the impact of SARS-CoV-2 on patient QoL, and remaining symptoms. Methods: Single center cross-sectional study of patients who had been admitted to our COVID-19 ward between March 2020 and March 2021. By applying a QoL questionnaire (EQ-5D-5L) we assessed the overall sample, at three time points and in different groups of patients: those admitted to the intensive care unit (ICU) and the elderly. Results: A total of 125 participants were included in our study. Most patients who were admitted had a severe course of disease (51%), with 22% of admissions to the ICU, with 8% requiring prone ventilation, 10% experiencing thrombotic complications and 18% of nosocomial infections throughout the admission. As for persistent symptoms related with COVID-19 fog, the most frequent were fatigue (57%), memory loss (52%) and insomnia (50%). Regarding QoL, the average decrease was 0.08 ± 0.2 in the index and 8.7 ± 19 in the Visual Analogue Scale (VAS). The QoL index decrease correlated with age, chronic obstructive pulmonary disease, asthma and heart failure, and all persistent symptoms, significantly. QoL VAS correlated significantly with fatigue, mood changes, difficulty concentrating and memory loss. The decrease in QoL and the persistent symptoms remained overall stable over the three time points. The ICU group showed no statistically significant difference in QoL, but the most frequently persistent symptoms were mood changes and attention disturbances. However, the elderly experienced a worsening in QoL expressed by index (0.69 ± 0.3 vs 0.8 ± 0.2, p-value = 0.01). Conclusion: A decrease in QoL was observed following SARS-CoV-2 infection, correlating with both chronic conditions and persistent symptoms. The lack of difference through time points of both QoL and persistent symptoms suggests a long-standing effect.en
dc.description.versionpublishersversion
dc.description.versionpublished
dc.format.extent8
dc.format.extent381764
dc.identifier.doi10.20344/amp.18784
dc.identifier.issn0870-399X
dc.identifier.otherPURE: 113189219
dc.identifier.otherPURE UUID: cf93bd2d-a76f-4362-8e6f-2463cd30a5c6
dc.identifier.otherScopus: 85162998647
dc.identifier.otherPubMed: 36790319
dc.identifier.urihttp://hdl.handle.net/10362/180873
dc.identifier.urlhttps://www.scopus.com/pages/publications/85162998647
dc.language.isoeng
dc.peerreviewedyes
dc.subjectCOVID-19
dc.subjectMental Fatigue
dc.subjectMental Status and Dementia Tests
dc.subjectPatient Reported Outcome Measures
dc.subjectQuality of Life
dc.subjectSARS-CoV-2
dc.subjectGeneral Medicine
dc.subjectSDG 3 - Good Health and Well-being
dc.titleThe Prevalence of COVID-19 Fog and the Impact on Quality of Life After SARS-CoV-2 Infection (QoL-COVID)en
dc.title.subtitleA Cross Sectional Studyen
dc.typejournal article
degois.publication.firstPage631
degois.publication.issue10
degois.publication.lastPage638
degois.publication.titleActa Medica Portuguesa
degois.publication.volume36
dspace.entity.typePublication
rcaap.rightsopenAccess

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura
Nome:
631-638.pdf
Tamanho:
372.82 KB
Formato:
Adobe Portable Document Format
Ver/Abrir

Coleções

NMS: CEDOC - Artigos em revista nacional com arbitragem científica